Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

By Nate Raymond BOSTON, May 18 (Reuters) - A U.S. jury on Monday found that Takeda Pharmaceutical caused purchasers of medications and insurers to sustain about $885 million in damages by delaying the release of a generic version of its constipation treatment Amitiza through an anticompetitive scheme.

Who wins Survivor 50? (How past gameplay could sway the jury votes)

We've narrowed down the competition to our Final Five players, but is this season the only one contributing to their win?
WFMJ

Jury selected in trial of man accused in fatal Coitsville crash

YOUNGSTOWN - A jury has been seated in the trial of a North Carolina man who is charged in connection with a dealy crash in Coitsville. A spokesperson for the Mahoning County Prosecutor’s Office tells 21 News the jury has been seated in the trial of Robert Powell,